BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 1079792)

  • 1. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Oct; 16(4):539-49. PubMed ID: 1080750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 6. An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas.
    Pross HF; Kerbel RS
    J Natl Cancer Inst; 1976 Nov; 57(5):1157-67. PubMed ID: 1087351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S; Smith RT
    Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells.
    Forman J; Britton S
    J Exp Med; 1973 Feb; 137(2):369-86. PubMed ID: 4539847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the effect of a thymic humoral factor on differentiation of thymus-derived lymphocytes.
    Lonai P; Mogilner B; Rotter V; Trainin N
    Eur J Immunol; 1973 Jan; 3(1):21-6. PubMed ID: 4146225
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
    Herberman RB; Nunn ME; Holden HT; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stimulatory effects of bearing primary methylcholanthrene-induced tumors upon the murine lymphoreticular system.
    Smith RT; Konda S
    Int J Cancer; 1973 Nov; 12(3):577-88. PubMed ID: 4598649
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage.
    Ushio-Umeda Y; Yoshida R
    Microbiol Immunol; 1997; 41(12):981-90. PubMed ID: 9492184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin and other surface antigens of cells of the immune system.
    Takahashi T; Old LJ; McIntire KR; Boyse EA
    J Exp Med; 1971 Oct; 134(4):815-32. PubMed ID: 4106485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for splenic suppressor cells in C3H/He, T-cell-deprived C3H/He, and nude mice bearing a 3-methylcholanthrene-induced fibrosarcoma.
    Poupon MF; Kolb JP; Lespinats G
    J Natl Cancer Inst; 1976 Dec; 57(6):1241-7. PubMed ID: 1087353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicity.
    Bataillon G; Pross H; Klein G
    Int J Cancer; 1975 Aug; 16(2):255-65. PubMed ID: 1150353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for two factors in sera of tumor-immunized mice which induce specific lymphoid cell-dependent cytotoxicity: IgG2 and a rapidly appearing factor not associated with IgG or IgM.
    Pollack SB; Nelson K
    Int J Cancer; 1975 Aug; 16(2):339-46. PubMed ID: 1150357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro.
    Gordon J; Murgita RA; Tomasi TB
    J Immunol; 1975 Jun; 114(6):1808-12. PubMed ID: 805179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.